For instance, αO‐Conotoxin GeXIVA, a potent antagonist for the α9α10 nAChR subtype, inhibits proliferation in MDA‐MB‐157 breast cancer cells through down‐regulation of this nAChR and induces cell cycle arrest [74, 85]. This evidence concerns the gene CHRNA4 and breast cancer.